Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Terada

Showing results (511-520 of 525) with videos related to

Pageof 53
Sort By:
Bone Marrow Transplantation|March 19, 2008
Prognostic value of serum surfactant protein D level prior to transplant for the development of bronchiolitis obliterans syndrome and idiopathic pneumonia syndrome following allogeneic hematopoietic stem cell transplantationT Nakane, H Nakamae, H Kamoi, et al.
European Journal of Biochemistry|April 15, 1997
A target of phosphatidylinositol 3,4,5-trisphosphate with a zinc finger motif similar to that of the ADP-ribosylation-factor GTPase-activating protein and two pleckstrin homology domainsK Tanaka, S Imajoh-Ohmi, T Sawada, et al.
Gynecologic Oncology|December 8, 2004
Polymorphisms of interleukin (IL)-1alpha, IL-1beta, IL-6, IL-10, and IL-18 and the risk of ovarian cancerAbigail W Bushley, Robert Ferrell, Katharine McDuffie, et al.
Haematologia|June 1, 2002
Clinical significance of serum E-cadherin levels in patients with haematological malignanciesT Takubo, H Kanashima, Y Terada, et al.
Haematologia|November 5, 2002
Serum sialyl Lewis(x) levels in patients with various haematologic malignanciesT Takubo, H Shibata, Y Terada, et al.
Haematologia|September 24, 2002
Clinical significance of serum E-selectin levels in patients with various haematologic malignanciesT Takubo, H Kanashima, Y Terada, et al.
American Journal of Epidemiology|September 26, 2003
Reproductive factors and epithelial ovarian cancer risk by histologic type: a multiethnic case-control studyKo-Hui Tung, Marc T Goodman, Anna H Wu, et al.
Gynecologic Oncology|June 1, 1996
Intraperitoneal mitoxantrone or floxuridine: effects on time-to-failure and survival in patients with minimal residual ovarian cancer after second-look laparotomy--a randomized phase II study by theSouthwest Oncology GroupF M Muggia, P Y Liu, D S Alberts, et al.
Vox Sanguinis|August 25, 2001
Primary refractoriness to platelet transfusion caused by Nak(a) antibody aloneH Fujino, K Ohta, J Taniue, et al.
Haematologia|September 24, 2002
E-cadherin expression in lymph nodes of three patients with non-Hodgkin's lymphomaT Takubo, H Kanashima, Y Terada, et al.
Pageof 53

Showing results (511-520 of 525) with videos related to

Sort By:
Pageof 53
Bone Marrow Transplantation|March 19, 2008
Prognostic value of serum surfactant protein D level prior to transplant for the development of bronchiolitis obliterans syndrome and idiopathic pneumonia syndrome following allogeneic hematopoietic stem cell transplantationT Nakane, H Nakamae, H Kamoi, et al.
European Journal of Biochemistry|April 15, 1997
A target of phosphatidylinositol 3,4,5-trisphosphate with a zinc finger motif similar to that of the ADP-ribosylation-factor GTPase-activating protein and two pleckstrin homology domainsK Tanaka, S Imajoh-Ohmi, T Sawada, et al.
Gynecologic Oncology|December 8, 2004
Polymorphisms of interleukin (IL)-1alpha, IL-1beta, IL-6, IL-10, and IL-18 and the risk of ovarian cancerAbigail W Bushley, Robert Ferrell, Katharine McDuffie, et al.
Haematologia|June 1, 2002
Clinical significance of serum E-cadherin levels in patients with haematological malignanciesT Takubo, H Kanashima, Y Terada, et al.
Haematologia|November 5, 2002
Serum sialyl Lewis(x) levels in patients with various haematologic malignanciesT Takubo, H Shibata, Y Terada, et al.
Haematologia|September 24, 2002
Clinical significance of serum E-selectin levels in patients with various haematologic malignanciesT Takubo, H Kanashima, Y Terada, et al.
American Journal of Epidemiology|September 26, 2003
Reproductive factors and epithelial ovarian cancer risk by histologic type: a multiethnic case-control studyKo-Hui Tung, Marc T Goodman, Anna H Wu, et al.
Gynecologic Oncology|June 1, 1996
Intraperitoneal mitoxantrone or floxuridine: effects on time-to-failure and survival in patients with minimal residual ovarian cancer after second-look laparotomy--a randomized phase II study by theSouthwest Oncology GroupF M Muggia, P Y Liu, D S Alberts, et al.
Vox Sanguinis|August 25, 2001
Primary refractoriness to platelet transfusion caused by Nak(a) antibody aloneH Fujino, K Ohta, J Taniue, et al.
Haematologia|September 24, 2002
E-cadherin expression in lymph nodes of three patients with non-Hodgkin's lymphomaT Takubo, H Kanashima, Y Terada, et al.
Pageof 53